KASINGER JAMES R.
General Counsel and Secretary
KASINGER JAMES R. has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Mar 24, 2026.
On the most recent filing, KASINGER JAMES R. is listed as General Counsel and Secretary at CRISPR Therapeutics AG. Inside the rolling window, KASINGER JAMES R. reported no open-market purchases and 5 open-market sales totaling $646K in CRSP. The largest disclosed transaction in the window is a sale of 3,450 CRSP shares on Mar 16, 2026, worth $166K.
Companies traded
Other insiders at CRSP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$646K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KASINGER JAMES R. made?
KASINGER JAMES R. has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does KASINGER JAMES R. trade?
KASINGER JAMES R. has filed SEC Form 4 disclosures for 1 company, including CRSP.
When was KASINGER JAMES R.'s most recent SEC Form 4 filing?
KASINGER JAMES R.'s most recent SEC Form 4 filing on Tracefour is dated Mar 24, 2026.
What is KASINGER JAMES R.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, KASINGER JAMES R. is listed as General Counsel and Secretary.
What is KASINGER JAMES R.'s total buy and sell value in the current window?
Inside the rolling retention window, KASINGER JAMES R. bought $0 and sold $646K based on SEC Form 4 filings.
What was KASINGER JAMES R.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 3,450 CRSP shares on 2026-03-16, worth $166K, per SEC Form 4 filings.